The haplotype of three polymorphisms in the SATB1 promoter region impacts survival in breast cancer patients.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 24932280)

Published in Oncol Lett on March 20, 2014

Authors

Martin Heubner1, Rainer Kimmig2, Bahriye Aktas2, Winfried Siffert3, Ulrich H Frey4

Author Affiliations

1: Institute of Pharmacogenetics, University of Duisburg-Essen, Essen D-45122, Germany ; Department of Obstetrics and Gynaecology, University of Duisburg-Essen, Essen D-45122, Germany.
2: Department of Obstetrics and Gynaecology, University of Duisburg-Essen, Essen D-45122, Germany.
3: Institute of Pharmacogenetics, University of Duisburg-Essen, Essen D-45122, Germany.
4: Institute of Pharmacogenetics, University of Duisburg-Essen, Essen D-45122, Germany ; Department of Anesthesiology and Intensive Care Medicine, University of Duisburg-Essen, Essen D-45122, Germany.

Articles cited by this

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27

Tissue-specific nuclear architecture and gene expression regulated by SATB1. Nat Genet (2003) 3.63

A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell (1992) 3.46

SATB1 targets chromatin remodelling to regulate genes over long distances. Nature (2002) 3.10

The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer (2005) 2.69

SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells. Dev Cell (2009) 2.57

The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes Dev (2000) 2.49

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. Clin Cancer Res (2008) 2.27

The mRNA expression of SATB1 and SATB2 in human breast cancer. Cancer Cell Int (2009) 1.62

Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer. J Thorac Oncol (2011) 1.33

Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells. Cancer Sci (2009) 1.21

Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma. J Dermatol Sci (2011) 1.20

SATB1 gene expression and breast cancer prognosis. Breast (2010) 1.18

The BCL2 gene is regulated by a special AT-rich sequence binding protein 1-mediated long range chromosomal interaction between the promoter and the distal element located within the 3'-UTR. Nucleic Acids Res (2011) 1.16

Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer. Oligonucleotides (2011) 1.00

Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells. Oncol Lett (2012) 0.92

The X factor: skewing X inactivation towards cancer. Cell (2007) 0.89

A role for SATB1, a nuclear matrix association region-binding protein, in the development of CD8SP thymocytes and peripheral T lymphocytes. J Immunol (2005) 0.87